Yiliyaer Nijiati
Ueruemqi, 830011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Multi-omics analyses reveal that hesperidin ameliorates high-altitude pulmonary hypertension by restoring gut-lung axis homeostasis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 28, 2025
Mechanism of ferroptosis in hypoxia-induced pulmonary vascular remodeling in hypoxia pulmonary hypertension: a study based on the ACE2-Ang-(1-7)-Mas axis.
Journal: Chemico-biological interactions
Published: March 17, 2025
18β-glycyrrhetinic acid improves pulmonary hypertension by regulating the vascular non-inflammatory molecule-1/L-arginine/nitric oxide signaling pathway.
Journal: European journal of pharmacology
Published: October 05, 2024
Effects of the ACE2-Ang-(1-7)-Mas axis on gut flora diversity and intestinal metabolites in SuHx mice.
Journal: Frontiers in microbiology
Published: April 05, 2024
Research on the improvement of oxidative stress in rats with high-altitude pulmonary hypertension through the participation of irbesartan in regulating intestinal flora.
Journal: European review for medical and pharmacological sciences
Published: July 21, 2021
iTRAQ-based quantitative proteomic analysis of the improved effects of total flavones of Dracocephalum Moldavica L. in chronic mountain sickness.
Journal: Scientific reports
Published: April 03, 2021
A 1H NMR spectroscopic metabolomic study of the protective effects of irbesartan in a rat model of chronic mountain sickness.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 25, 2021
Irbesartan ameliorates chronic mountain sickness in a rat model via the cholesterol metabolism: An iTRAQ -based proteomics analysis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 24, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026